Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

XINLU LIU

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1831553502
CMS profile
5962113
Location
COLUMBIA, SC

General Payments · PY2019–2024

$3,100.55

  • Reported across 118 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$703.42

40 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $703.42 40

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $74.34 1
PY2020 $148.23 2
PY2021 $564.61 7
PY2022 $690.70 28
PY2023 $919.25 40
PY2024 $703.42 40

Payment records · PY2024 (40)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $21.52 02/13/2024 Food and Beverage Undisputed 01/23/2026 1125296364 CMS
Abbott Laboratories $24.20 12/04/2024 Food and Beverage Undisputed 01/23/2026 1125296366 CMS
ABBVIE INC. $14.03 01/18/2024 Food and Beverage Undisputed 01/23/2026 1104892337 CMS
ABBVIE INC. $18.87 02/21/2024 Food and Beverage Undisputed 01/23/2026 1104892339 CMS
ABBVIE INC. $14.03 03/13/2024 Food and Beverage Undisputed 01/23/2026 1104892341 CMS
ABBVIE INC. $11.25 04/03/2024 Food and Beverage Undisputed 01/23/2026 1104892343 CMS
ABBVIE INC. $16.50 04/09/2024 Food and Beverage Undisputed 01/23/2026 1104892345 CMS
ABBVIE INC. $8.89 06/12/2024 Food and Beverage Undisputed 01/23/2026 1104892347 CMS
ABBVIE INC. $17.85 06/13/2024 Food and Beverage Undisputed 01/23/2026 1104892349 CMS
ABBVIE INC. $1.17 08/13/2024 Food and Beverage Undisputed 01/23/2026 1104892351 CMS
ABBVIE INC. $14.39 08/14/2024 Food and Beverage Undisputed 01/23/2026 1104892353 CMS
ABBVIE INC. $13.26 09/03/2024 Food and Beverage Undisputed 01/23/2026 1104892355 CMS
ABBVIE INC. $9.37 10/22/2024 Food and Beverage Undisputed 01/23/2026 1104892357 CMS
ABBVIE INC. $10.33 11/06/2024 Food and Beverage Undisputed 01/23/2026 1104892359 CMS
AstraZeneca Pharmaceuticals LP $13.59 01/23/2024 Food and Beverage Undisputed 01/23/2026 1105862006 CMS
AstraZeneca Pharmaceuticals LP $15.89 02/08/2024 Food and Beverage Undisputed 01/23/2026 1105617965 CMS
AstraZeneca Pharmaceuticals LP $13.68 03/01/2024 Food and Beverage Undisputed 01/23/2026 1104341044 CMS
Bayer Healthcare Pharmaceuticals Inc. $22.75 09/04/2024 Food and Beverage Undisputed 01/23/2026 1086151061 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.91 09/12/2024 Food and Beverage Undisputed 01/23/2026 1118173915 CMS
CeQur Corporation $28.29 01/24/2024 Food and Beverage Undisputed 01/23/2026 1126847090 CMS
Corcept Therapeutics $21.08 11/13/2024 Food and Beverage Undisputed 01/23/2026 1117760108 CMS
Exact Sciences Corporation $14.58 04/24/2024 Food and Beverage Undisputed 01/23/2026 1114760143 CMS
Exact Sciences Corporation $17.90 12/18/2024 Food and Beverage Undisputed 01/23/2026 1114760149 CMS
GlaxoSmithKline, LLC. $17.47 02/08/2024 Food and Beverage Undisputed 01/23/2026 1116231533 CMS
GlaxoSmithKline, LLC. $16.48 06/10/2024 Food and Beverage Undisputed 01/23/2026 1116658091 CMS
GlaxoSmithKline, LLC. $16.19 08/29/2024 Food and Beverage Undisputed 01/23/2026 1116489066 CMS
GlaxoSmithKline, LLC. $15.42 10/10/2024 Food and Beverage Undisputed 01/23/2026 1116416367 CMS
Inari Medical, Inc. $51.90 10/08/2024 Food and Beverage Undisputed 01/23/2026 1140131690 CMS
Lilly USA, LLC $25.60 06/27/2024 Food and Beverage Undisputed 01/23/2026 1135455059 CMS
Novartis Pharmaceuticals Corporation $18.75 01/25/2024 Food and Beverage Undisputed 01/23/2026 1086989944 CMS
Novartis Pharmaceuticals Corporation $19.62 09/25/2024 Food and Beverage Undisputed 01/23/2026 1086989948 CMS
Novo Nordisk Inc $13.34 02/23/2024 Food and Beverage Undisputed 01/23/2026 1097546531 CMS
Novo Nordisk Inc $21.08 05/15/2024 Food and Beverage Undisputed 01/23/2026 1097386036 CMS
Novo Nordisk Inc $24.00 08/20/2024 Food and Beverage Undisputed 01/23/2026 1096827027 CMS
Novo Nordisk Inc $23.00 08/28/2024 Food and Beverage Undisputed 01/23/2026 1097623641 CMS
PFIZER INC. $16.30 01/31/2024 Food and Beverage Undisputed 01/23/2026 1130987123 CMS
PFIZER INC. $14.30 05/14/2024 Food and Beverage Undisputed 01/23/2026 1131429397 CMS
PFIZER INC. $20.74 06/26/2024 Food and Beverage Undisputed 01/23/2026 1131680580 CMS
PFIZER INC. $15.64 09/05/2024 Food and Beverage Undisputed 01/23/2026 1131933334 CMS
PFIZER INC. $15.26 12/03/2024 Food and Beverage Undisputed 01/23/2026 1131210102 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.